Format
Sort by

Send to:

Choose Destination

Results: 5

Related Articles by Review for PubMed (Select 21558517)

1.

Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.

Najjar SS, Rao SV, Melloni C, Raman SV, Povsic TJ, Melton L, Barsness GW, Prather K, Heitner JF, Kilaru R, Gruberg L, Hasselblad V, Greenbaum AB, Patel M, Kim RJ, Talan M, Ferrucci L, Longo DL, Lakatta EG, Harrington RA; REVEAL Investigators.

JAMA. 2011 May 11;305(18):1863-72. doi: 10.1001/jama.2011.592.

2.

Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.

Gao D, Ning N, Niu X, Dang Y, Dong X, Wei J, Zhu C.

Am Heart J. 2012 Nov;164(5):715-727.e1. doi: 10.1016/j.ahj.2012.07.031. Epub 2012 Oct 16. Review.

PMID:
23137502
3.

Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients.

van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y, Atar D, Buser P, Wu E, Lee D, Bodi V, Klug G, Metzler B, Delewi R, Bernhardt P, Rottbauer W, Boersma E, Zijlstra F, van Geuns RJ.

JACC Cardiovasc Imaging. 2014 Sep;7(9):930-9. doi: 10.1016/j.jcmg.2014.05.010. Review.

PMID:
25212799
4.

Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials.

Abdelnoor M, Sandven I, Limalanathan S, Eritsland J.

Vasc Health Risk Manag. 2014 Aug 8;10:477-91. doi: 10.2147/VHRM.S67154. eCollection 2014. Review.

5.

Administration of erythropoietin in patients with myocardial infarction: does it make sense? An updated and comprehensive meta-analysis and systematic review.

Ali-Hassan-Sayegh S, Mirhosseini SJ, Tahernejad M, Mahdavi P, Haddad F, Shahidzadeh A, Lotfaliani MR, Sedaghat-Hamedani F, Kayvanpour E, Weymann A, Sabashnikov A, Popov AF.

Cardiovasc Revasc Med. 2015 Apr-May;16(3):179-189. doi: 10.1016/j.carrev.2015.01.008. Epub 2015 Jan 29. Review.

PMID:
25704158
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk